Calidi BiotherapeuticsCLDI
13F holders, Q3 2024 (September 30)20holders +18
6new positions
2sold out
$1.14avg. 13F price*
At the end of Q3 2024, 20 institutions reported holding Calidi Biotherapeutics Inc. (CLDI) in their 13F filings, up 18 from Q2 2024. 6 opened new positions and 2 sold out. The largest holders were Cable Car Capital, LP ($95K), CPR Investments Inc. ($64K) and Red Wave Investments LLC ($53K).
- Company
- Calidi Biotherapeutics Inc.
- CUSIP
- 320703309
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $94K |
| Exits | 2 | $31K |
All 13F filers, Q2 2024 → Q3 2024: 168,320 shares bought and 172,565 shares sold, net −4,246 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Cable Car Capital, LP | 0.11% | Add +7254.5% | 82,937 | $95K |
| CPR Investments Inc. | 0.06% | No change | 56,000 | $64K |
| Red Wave Investments LLC | 0.02% | Reduce -25.6% | 46,461 | $53K |
| Geode Capital Management, LLC | 0.00% | New | 39,612 | $45K |
| Susquehanna International Group, LLP | 0.00% | New | 23,544 | $27K |
| Delta Investment Management, LLC | 0.00% | No change | 21,023 | $24K |
| Apollo Management Holdings, L.P. | 0.00% | New | 12,500 | $14K |
| Finepoint Capital LP | 0.00% | No change | 12,500 | $14K |
| Evermay Wealth Management LLC | 0.00% | New | 6,342 | $7K |
| Highbridge Capital Management LLC | 0.00% | No change | 6,250 | $7K |
| 683 Capital Management, LLC | 0.00% | No change | 3,788 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +335.9% | 3,671 | $4K |
| Morgan Stanley | 0.00% | Add +5.2% | 2,019 | $2K |
| UBS Group AG | 0.00% | Add +92100.0% | 922 | $1K |
| CVA Family Office, LLC | 0.00% | No change | 500 | $570 |
| BlackRock, Inc. | 0.00% | — | 259 | $295 |
| Osaic Holdings, Inc. | 0.00% | Add +0.2% | 253 | $288 |
| FMR LLC | 0.00% | New | 141 | $161 |
| Bank of America Corp. | 0.00% | Add +75.8% | 48 | $55 |
| Householder Group Estate & Retirement Specialist, LLC | 0.00% | New | 500 | $0 |
"% of holder's portfolio" is CLDI's weight in each manager's 13F, not the share of Calidi Biotherapeutics Inc. the manager owns.